Cargando…
Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer
Currently, there is no serum marker that is routinely recommended for lung cancer. Therefore, the aim of the present study was to demonstrate that plasma vascular endothelial growth factor 165 (VEGF 165) may be a potential marker for advanced lung cancer. Lung cancer is the leading cause of cancer-r...
Autores principales: | ABDALLAH, AHMED, BELAL, MOHAMED, EL BASTAWISY, AHMED, GAAFAR, RABAB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049695/ https://www.ncbi.nlm.nih.gov/pubmed/24932301 http://dx.doi.org/10.3892/ol.2014.2016 |
Ejemplares similares
-
Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin
por: Gaafar, Rabab, et al.
Publicado: (2014) -
Effects of Vascular Endothelial Growth Factor 165 on Bone Tissue Engineering
por: Feng, Lin, et al.
Publicado: (2013) -
Levels of vascular endothelial growth factor-A(165b) (VEGF-A(165b)) are elevated in experimental glaucoma
por: Ergorul, Ceren, et al.
Publicado: (2008) -
Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF(165)) Structure
por: Nemashkalova, Ekaterina L., et al.
Publicado: (2023) -
Transplantation of vascular endothelial growth factor 165-transfected endothelial progenitor cells for the treatment of limb ischemia
por: WANG, SHENG, et al.
Publicado: (2015)